StockData
TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW

Translational Development Acquisition Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.81−0.02 (-0.16%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

20 of Translational Development Acquisition's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QJun 30, 2026Aug 14, 2026SEC EDGAR
Current report8-KJul 27, 2026Jul 27, 2026SEC EDGAR
Current report8-KJul 6, 2026Jul 8, 2026SEC EDGAR
Current report8-KJun 22, 2026Jun 23, 2026SEC EDGAR
Current report8-KJun 17, 2026Jun 18, 2026SEC EDGAR
Current report8-KJun 12, 2026Jun 12, 2026SEC EDGAR
Proxy statementDEF 14AJun 17, 2026May 27, 2026SEC EDGAR
Current report8-KMay 27, 2026May 27, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 15, 2026SEC EDGAR
Annual report, amended10-K/ADec 31, 2025May 11, 2026SEC EDGAR
Annual report, amended10-K/ADec 31, 2025May 6, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 30, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 14, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 14, 2025SEC EDGAR
Current report8-KAug 8, 2025Aug 14, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 15, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 31, 2025SEC EDGAR
Current report8-KFeb 14, 2025Feb 14, 2025SEC EDGAR
Current report8-KDec 24, 2024Dec 31, 2024SEC EDGAR
Current report8-KDec 20, 2024Dec 27, 2024SEC EDGAR